Abstract
The role of alpha-2 receptors and alpha-2 antagonists in central and peripheral mechanisms of sexual response are discussed. It is concluded that the predominant role of the alpha-2 antagonist centrally is to increase arousal which in certain circumstances, is sexual. It is further concluded that the predominant role of the alpha-2 antagonist peripherally is to modulate (block) the norepinephrine (NE)-induced contractility in the smooth muscle of the penis. How the central arousal mechanisms are specifically linked to sexual response is not understood.
Experimental studies with a selective alpha-2 antagonist, delequamine, are briefly reviewed and their complex results discussed. Evidence from sleep studies was consistent with delequamine having both central excitatory and inhibitory effects, dependent on dosage. The possibility that men with psychogenic erectile dysfunction might have increased central alpha-2 tone was considered. The apparent loss of responsiveness to the alpha-2 antagonist in older dysfunctional men was discussed. More questions are raised than answered; further research is needed in this area.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bancroft, J. Effects of alpha-2 blockade on sexual response: experimental studies with Delequamine (RS15385). Int J Impot Res 12 (Suppl 1), S64–S69 (2000). https://doi.org/10.1038/sj.ijir.3900507
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3900507
Keywords
This article is cited by
-
Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial
International Journal of Impotence Research (2002)
-
Central nervous system agents in the treatment of erectile dysfunction: How do they work?
Current Urology Reports (2001)